Collectively, our findings indicated that KRT8 can be used as a predictor of prognosis in ccRCC patients after partial or radical nephrectomy, especially in patients with early stage localized ccRCC (pT stages I and II). Here, KRT8 is linked to nonpapillary renal cell carcinoma.